Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nursing Implementation01:15

Nursing Implementation

6.2K
Implementation is the execution of the nursing care plan developed during the planning phase.
The five steps to implementing effective nursing care include reassessing the patient, reviewing and revising the existing nursing care plan, organizing the resources and care delivery, anticipating and preventing complications, and implementing nursing interventions.
6.2K
Stages of Infection01:26

Stages of Infection

65.3K
Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...
65.3K
Stages of General Anesthesia01:22

Stages of General Anesthesia

1.7K
Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.7K
Stages of Sleep01:22

Stages of Sleep

1.5K
Sleep progresses through distinct stages, each characterized by specific brain wave patterns and physiological responses ranging from wakefulness to stages of non-rapid eye movement, known as non-REM, to rapid eye movement, referred to as REM. Understanding these stages helps in recognizing how sleep supports various bodily and cognitive functions.
Before sleep begins, in wakefulness, the brain exhibits primarily beta waves, which are high in frequency and low in amplitude, indicating alertness...
1.5K
Psychosexual Stages of Personality: Oral01:16

Psychosexual Stages of Personality: Oral

3.2K
The oral stage is the initial phase of Sigmund Freud's theory of psychosexual development, occurring from birth to approximately 12 to 18 months. During this period, the infant's mouth serves as the primary source of pleasure, with actions such as sucking, chewing, biting, and drinking playing a crucial role in reducing tension. These activities are essential not only for nourishment but also for the infant's psychological and emotional satisfaction.
Weaning, typically occurring...
3.2K
Psychosexual Stages of Personality: Anal01:26

Psychosexual Stages of Personality: Anal

4.1K
Sigmund Freud's theory of psychosexual development describes the anal stage as occurring between 18 months and three years of age. During this period, children derive pleasure from controlling and releasing their bowel movements. However, they quickly learn that societal expectations impose restrictions on when and where this can happen. This stage marks a critical point where children begin to develop a sense of control and mastery over their bodily functions, as well as their broader...
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Context-dependent selection sculpts mutational landscapes in the normal lung.

Research square·2026
Same author

Reply to: "On the Distinction Between Prognostic and Predictive Inference in Multicancer Early Detection" and "Interpretation of Survival Outcomes in Multicancer Early Detection Testing Requires Caution".

JCO precision oncology·2026
Same author

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence.

EBioMedicine·2026
Same author

Plasma signals of lung tumor promotion for molecular cancer prevention.

Cell·2026
Same author

Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation.

Nature machine intelligence·2026
Same author

Nociceptive innervation limits tertiary lymphoid structures to promote lung cancer.

Cell·2026

Related Experiment Video

Updated: Feb 8, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.4K

Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.

Christopher Abbosh1, Nicolai J Birkbak1,2, Charles Swanton3,4

  • 1Cancer Research UK Lung Cancer Centre of Excellence London and Manchester, University College London Cancer Institute, London, UK.

Nature Reviews. Clinical Oncology
|July 4, 2018
PubMed
Summary

Circulating tumor DNA (ctDNA) shows promise for early cancer detection and monitoring residual disease. This analysis, particularly in non-small cell lung cancer, can improve patient outcomes through timely intervention and risk stratification.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K
Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

584

Related Experiment Videos

Last Updated: Feb 8, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

17.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.1K
Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors
05:46

Fluorescence-Based Detection of FEN1 Nuclease Activity and Screening of Small-Molecule Inhibitors

Published on: June 27, 2025

584

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Circulating tumor DNA (ctDNA) is cell-free DNA from tumors, gaining interest for early cancer detection and improved therapeutic outcomes.
  • ctDNA analysis may identify high-risk patients for recurrence in the adjuvant setting by detecting minimal residual disease (MRD).
  • Current technologies may enable risk stratification and adaptation of adjuvant clinical trials using ctDNA.

Purpose of the Study:

  • To evaluate contemporary next-generation sequencing (NGS) approaches for ctDNA detection.
  • To focus on ctDNA profiling in non-small cell lung cancer (NSCLC).
  • To assess the feasibility of ctDNA profiling for cancer screening and MRD assessment.

Main Methods:

  • Review of current next-generation sequencing (NGS) technologies for ctDNA analysis.
  • Focus on technical and analytical challenges in low-frequency mutation detection via NGS-based ctDNA profiling.
  • Evaluation of ctDNA profiling in screening and MRD assessment contexts for NSCLC.

Main Results:

  • Advances in DNA sequencing and tumor biology fuel interest in ctDNA for early cancer detection and intervention.
  • ctDNA analysis shows potential for identifying post-surgical minimal residual disease (MRD) to predict recurrence risk.
  • The study evaluates NGS approaches for ctDNA detection, focusing on challenges and feasibility in NSCLC.

Conclusions:

  • ctDNA analysis holds significant potential for early cancer detection and optimizing adjuvant therapy through MRD assessment.
  • NGS-based ctDNA profiling presents technical and analytical challenges, particularly for low-frequency mutation detection.
  • ctDNA profiling is feasible for both screening and MRD assessment in contexts like non-small cell lung cancer, paving the way for improved risk stratification.